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Abstract 
Dengue is a vector borne disease transmitted by the Aedes Aegpti 
mosquito. The dengue virus is capable of causing dengue hemorrhagic fever 
(DHF) and dengue shock syndrome (DSS) potentially fatal forms of the disease 
with worldwide morbidity and mortality that has been increasing annually. Many 
strategies have been proposed to reduce the burden of this disease. Treatment for 
the various forms of the disease is supportive. Much research has been devoted to 
developing a vaccine to prevent this disease, but a safe and effective vaccine is 
not currently available. The research and difficulties surrounding the search for a 
vaccine will be discussed in this paper. Various forms of vector control have also 
been attempted over the past century with varying degrees of success. The history 
of the disease and vector control will be explored. 
This disease has been especially harmful to areas like Puerto Rico where 
the cost of dengue over the past ten years has been $250 million. This paper will 
include a systematic review of the literature to determine a feasible, cost effective 
and sustainable policy for long-term reduction of dengue-related morbidity and 
mortality in Puerto Rico. 
Focus of Paper/Question L 
In 1991 Gubler et al1 published a paper recommending a new policy to 
reduce morbidity and mortality caused by Dengue Hemorrhagic Fever (DHF) and 
Dengue Shock Syndrome (DSS) in Puerto Rico. The author outlines the available 
options at the time the article was published. The options were as follows: 
"Aedes aegypti eradication, ultra-low-volume (UL V) insecticide application, 
regulation of air travel, development and use of dengue vaccines, preventive 
measures keyed to improved surveillance, and routine mosquito control efforts". 1 
Gubler et al1 explains how the only viable options in 1991 are the last two: 
improved surveillance and routine mosquito control efforts and a five-component 
program is proposed that elaborates on these two options. The program includes 
1. proactive surveillance; 2. rapid-response emergency vector control; 3. long-
term, integrated community-based mosquito control; 4. education of the medical 
community; 5. an emergency hospitalization plan. This paper will review the 
literature from the time of the publishing of this article (1991) to the present to 
determine what policy has the best potential for limiting or decreasing morbidity 
and mortality from Dengue virus infection in Puerto Rico today.1 
BACKGROUND 
Epidemiology of the Disease 
Many aspects of Dengue virus infection have led to its emergence in 
recent years as a threat to human health that is increasingly difficult to control in 
areas like Puerto Rico where epidemics occur. Throughout the world's tropical 
regions the epidemics of Dengue are becoming larger and more frequent.2 
There is an estimated worldwide prevalence of 50-100 million cases of 
Dengue fever, 250-500 thousand cases of Dengue hemorrhagic fever, and 24,000 
deaths caused by Dengue per year.2 "Overall, it is estimated that in 2001 dengue 
was responsible for ... 653,000 Disability-Adjusted Life Years (DAL Ys)".3 The 
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cost of dengue over the past IO years in Puerto Rico alone has been $250 million.4 
By implementing an effective Dengue control policy, lives could be saved, 
morbidity could be reduced and money could be saved. 
Description of the vector 
The Aedes Aegypti mosquito transmits the dengue virus. Humans and 
mosquitoes are the primary hosts. In Africa and Asia the virus is thought to be 
sustained by vertical transmission in mosquitoes and amplified in other primates 
between human epidemics.2 This mosquito is an efficient vector for the virus. It 
lives in close proximity to humans and feeds primarily on human blood. It feeds 
during the day (early morning and late afternoon), its' bite is rarely noticed by 
humans and it can feed repeatedly during one life cycle? 
Because the mosquito is active both indoors and outdoors during the day, 
people have difficulty avoiding it, and interventions like bed nets are not helpful. 
In Asia and America it breeds primarily in manmade receptacles, however in 
Africa it breeds in natural water sources as well? However, this is not the only 
vector capable of carrying and infecting humans with Dengue. The Aedes 
albopictus has been incriminated in a recent outbreak in Hawaii and is an 
increasingly common inhabitant of the continental US.4 
Description of the disease 
Dengue is caused by four closely related flaviviruses (DEN-I, DEN-2, 
DEN-3, DEN-4). These four viruses are antigenically distinct and do not grant 
the victim cross-immunity (infection with DEN-I protects against future infection 
with DEN-I, but not DEN-2, a patient could be infected 4 times, once with each 
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serotype). In fact, secondary infection (infection with a different serotype) raises 
the likelihood of a severe form of Dengue infection, dengue hemorrhagic fever? 
The signs and symptoms of Dengue fever include "high fever, frontal 
headache, retro-orbital pain, myalgias, arthralgias, vomiting, and often a 
maculopapular rash.'"' Symptoms may range from unnoticeable to debilitating. 
Treatment for this form of the disease is supportive. Dengue Hemorrhagic Fever 
(DHF) and Dengue Shock Syndrome (DSS) are more severe and potentially fatal 
forms ofthe disease.4 
Patients may appear to have classic Dengue Fever at the beginning of this 
disease, however, when the fever subsides after 2-7 days "the patient may become 
restless or lethargic, show signs of circulatory failure, and experience 
hemorrhagic manifestations.'"' These hemorrhagic manifestations may include 
petechia, ecchymoses, purpura, bleeding from mucosa, etc. and may be 
demonstrated by a positive tourniquet test. The tourniquet test consists of 
inflating a blood pressure cuff around a patient's arm for five minutes and 
monitoring for the occurrence of petechiae. 5 
To be diagnosed with Dengue Hemorrhagic Fever (DHF) the patient must 
have a platelet count less than 100,000/mm3 and objective evidence of increased 
vascular permeability. DHF may then lead to Dengue shock syndrome (DSS), 
characterized by pulse pressure less than 20 mm Hg or hypotension. 2 There is no 
specific treatment for DHFfi)SS. Depending on diagnostic acumen and 
availability of intravenous fluids and blood for treatment of the hypovolemic 
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shock the mortality rate ranges from less than 1 o/o to greater than 30% for 
DHF/DSS.5 
Most cases of primary infection with the dengue virus produce mild 
symptoms or no symptoms at all. Symptoms of dengue fever caused by a primary 
infection are usually worse in older children or adults than in young children, 
however children are more susceptible to DHF/DSS during a secondary 
infection. 6 
History of Dengue and Early Control Efforts 
In order to have a better understanding of this disease and its potential for 
being controlled as well as its potential for causing harm, it is helpful to examine 
the history of the disease. This section of the paper will describe the history of 
the vector and the disease and the successes and failures of control efforts. 
History of the Aedes Aegypti 
In order to understand the distribution of this disease it is important 
to understand the history ofthis mosquito. By most accounts the mosquito 
originated in Africa, feeding on primates and reproducing in small areas of water, 
like holes in trees and crab burrows. The mosquito adapted to reproduce in small 
manmade water receptacles and feed primarily on human blood. Beginning with 
the slave trade in the 1500s the mosquito began breeding in water storage 
containers of shipping vessels and with this new form of transportation invaded 
other parts of the world. By 1930, with the help of human transportation, the 
mosquito had spread to almost all the geographic locations it;s biology would 
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allow. This is a map of the probable distribution of the vector at that time. 7 
The mosquito population began to plummet during the 1900s when 
eradication programs began. The mosquito was determined to be associated with 
yellow fever and dengue and the P AHO began to focus efforts on eradicating this 
species to prevent disease. During this time the US focused limited attention on 
this vector. Partially due to efforts to control malaria by breeding site destruction 
and pesticide use in the US and through strong efforts by other western 
hemisphere countries to eradicate yellow fever and dengue, the mosquito 
population dropped and dengue ceased to be a significant problem in the us? 
This map shows the vector distribution at its lowest point in 1970.7 
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The US officially stopped efforts to control Aedes Aegypti and eradication 
was discontinued completely in 1970. Other countries in the Western hemisphere 
began to decrease efforts to control the vector as well and the mosquitoes began to 
re-infest areas where it had previously been eradicated. At the present time the 
distribution ofthe vector is above the pre-intervention Ievel.4 
History of Dengue Illness 
Dengue illness has been recognized and written about for the past 200 
years, although the illness has only been associated with its' mosquito vector for 
the past 70 years.8 Epidemics were first reported in I 779-1780. These epidemics 
occurred in Asia, Africa, and North America. In the beginning these epidemics 
caused little mortality and epidemics were infrequent, occurring every few 
decades.9 
Following World War IT a global pandemic of dengue began. With the 
continued increase in world travel, dengue strains began to effect different regions 
of the world and the virus reached a state of hyperendemicity in many regions. 
Hyperendemicity describes a state in which multiple serotypes of the virus are 
circulating in the same region. As can be reasoned from the previous discussion, 
this creates a very dangerous environment in which people become at risk for 
multiple infections with different virus serotypes and ultimately, dengue 
hemorrhagic fever (DHF). The first known epidemic ofDHF occurred in 1953 in 
the Philippines and marks the turning point in the history of the dengue virus. At 
this time the virus switched from a relatively benign infectious agent to a major 
cause of morbidity and mortality.9 
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During the next 20 years epidemics of dengue hemorrhagic fever spread 
throughout Southeast Asia and became one of the leading causes of 
hospitalization and death for children in this region. During the same period of 
time however, dengue was not active in the Americas, because the vector had 
been temporarily eradicated. In the 1970s the situation changed. The vector 
began to repopulate the Americas and Pacific Islands and with the vector came 
the virus. During the 1980s and 1990s DHF epidemics arrived to many countries 
in the Western Hemisphere that had never before experienced this form of the 
disease.9 
Over the past twenty years dengue has become an increasing problem. 
There are several factors that are thought to be responsible for this increase. The 
first factor is global population growth. With this dramatic growth in the human 
population has come a dramatic increase in substandard housing and poorly 
managed water, waste and sewage. People living in these conditions often gather 
clean water when it is available in as many containers as possible. Along with an 
increased production of items like tires and manmade plastic containers and a lack 
of garbage removal, these factors have provided a new abundance of small areas 
of standing water that make perfect breeding sites for mosquitoes. All of these 
factors together lead to a large population of humans in close proximity to each 
other and to mosquito breeding sites. This is the perfect environment for dengue 
transmission.9 
Another factor that may have contributed to the increase in dengue 
incidence is the ineffective control methods that have been used. During the 
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1970s through the 1990s the control method most commonly used was space 
spraying with insecticide. This method killed adult mosquitoes, but had little 
lasting effect on the mosquito population. Also, it gave people a false sense of 
security that the mosquito problem was being treated and people in endemic areas L 
stopped participation in helpful control efforts like removing and emptying water 
containers that served as mosquito breeding sites.9 
In addition, over the past several decades air travel has continued to 
increase making it difficult to contain dengue serotypes. Also, lack of resources 
in dengue endemic regions has led to a decay of public health infrastructure 
making it difficult for countries to respond to epidemics in an effective way.9 
Future trends 
The phenomenon of global warming is predicted to have a profound effect 
on the distribution of dengue and its vector. The WHO has predicted that a 
temperature increase of 1-2 degrees Celsius would increase the population at risk 
by several hundred million and fatalities by 20,000-30,000.6 It is also estimated 
that the factors mentioned above that have led to an increase in dengue incidence 
(i.e.: increase in air travel, increase in plastic containers) will continue to 
contribute to the problem in the coming decades.9 With past failures to control the 
disease in mind, and bleak predictions for expansion of the disease in the future, 
finding the best policy for dengue control for the present is vital. 
Current Policies to Control Dengue 
Gubler et al1 presented the following policies for dengue virus control in 
Puerto Rico in 1991: "Aedes Aegypti eradication, ultra-low-volume (ULV) 
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insecticide application, regulation of air travel, development and use of dengue 
vaccines, preventive measures keyed to improved surveillance, and routine 
mosquito control efforts." The program proposed by Gubler et al1 has five 
components based on the last two options. These components are: 1. proactive 
surveillance 2. rapid-response emergency vector contro13. long-term, integrated 
community-based mosquito control4. education of the medical community 5. an 
emergency hospitalization plan. The purpose of this proposed program would be 
to reduce dengue incidence and thus reduce the likelihood ofDHF/DSS cases in 
Puerto Rico.1 
Since publication of the 1991 article, the two policies most extensively 
researched, and the most widely advocated solutions to the dengue problem are 
vaccination and long-term, integrated community~ based mosquito control. 
However, a safe and effective vaccine for dengue is not currently available for 
human use. For this reason, recent research on dengue vaccines will be briefly 
reviewed, including information on the current status and predictions for the 
future. The remainder of the paper will be devoted to an in-depth analysis of 
long-term, integrated community-based mosquito control, because this is the 
policy currently available and most widely recommended. This paper will 
systematically review the research on this latter policy and evaluate the feasibility, 
cost effectiveness, acceptability, effectiveness and sustainability of the policy as 
defined by recent research. 
Methods 
Criteria 
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The criteria used to evaluate the policy included feasibility, cost effectiveness, 
acceptability, effectiveness and sustainability. 
Method for Finding Information 
Information sources 
CDC website, CDC Faculty (Gubler and Clark), Medline, article reference lists. 
Search Strategy for Background 
Searched with Medline MESH terms: Dengue and limited to English 
review articles for general background; used Dengue MESH term with 
subheading prevention and control limited to English for vector control 
background. Search included articles published from 1985 to the present, March 
2005. Also, the CDC and WHO websites on Dengue were used. 
Search Strategy for Results 
Search Strategy for Vaccine Section 
Searched Medline using MESH terms: "Dengue" and "Vaccine". This 
search was limited to the English language and included articles published from 
January 2004 to the present, March 31, 2005. This search was limited to include 
only the most recent articles. Articles were reviewed for relevance to the current 
topic and eleven of the nineteen articles are cited in this paper. 
Also, the CDC website on Dengue and the WHO website on Dengue were 
used as sources of information for this section. 
Search Strategy for Vector Control Section 
Searched with Medline MESH terms: "Mosquito Control"[MeSH] AND 
"Dengue/prevention and control"[MeSH]. This search was limited to articles written in 
the English Language and published between January I, 1991 AND March 14,2005. 
II 
This search yielded 95 articles. Articles that focused on the efficacy of specific 
insecticides, the behavior or biology of mosquitoes, vaccination or Dengue outbreaks 
among tourist were excluded by title. 
The 74 articles remaining were reviewed by title, abstract and full article to 
evaluate for internal validity using the following four selection criteria: 
I. Population: Were study participants or communities in a Dengue endemic region 
like Puerto Pico? (i.e.: not tourists). 
2. Study intervention: Did at least one study community or group participate in a 
long-term integrated community-based vector control program or a component of 
such a program? 
3. Control intervention: Was there a comparison group that received no 
intervention? If not was there a comparison intervention? 
4. Outcome: Was one of the outcomes measured feasibility, cost effectiveness, 
acceptability, efficacy or sustainability? Was efficacy measured in terms of 
reduction in morbidity or mortality from Dengue? Or was there a secondary 
marker such as mosquito count or increased knowledge? 
Nine articles met the four inclusion criteria outlined above. Although the best 
evidence would have been randomized controlled trials of this program in comparison to 
no intervention, this level of evidence was limited and other levels of evidence needed to 
be included in order to evaluate this program. In the results section of this paper I will 
review the information given in these nine articles and discuss the quality of evidence 
provided. 
Results 
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In this section ofthe paper I will briefly discuss development and use of 
dengue vaccines. I will then discuss the vector control policy proposed by Gubler 
in 1991, long-term integrated community-based mosquito control. Based on 
research conducted from 1991 to the present, I will determine how this policy 
meets the criteria I have chosen: feasibility, cost effectiveness, acceptability, 
sustainability, and efficacy. The following outlines how this results section will 
be structured. 
t. Development and use of Dengue Vaccines 
A. Why vaccine development is a problem 
B. Review of recent progress made in vaccine research 
C. Predictions about vaccine availability in the future 
II. Long-term integrated community-based mosquito control 
A. Definition of integrated community-based mosquito control L 
B. Review of research 
1. Swaddiwudhipong 
' 
_L__ 
2. Swaddiwudhipong 
I--
3. Lloyd 
4. Espinoza-Gomez 
5. Madeira 
6. Kay 
7. Winch 
8. Sanchez 
9. Kay 
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C. Table of Evidence 
I Development and use of dengue Vaccines 
Gubler et al1 stated: "Ultimately, prevention of epidemic DHF may 
depend on vaccination. At the present, however, no vaccines against dengue 
viruses are available for general use." The article goes on to speculate that a safe 
vaccine for dengue would not be available for at least ten years.1 Fourteen years 
after the publication of this article I will briefly review the progress made on 
vaccines for dengue and discuss why this option is not currently possible and 
when it is predicted to be available. 
I A. Why vaccine development is a problem 
There are some attributes of the Dengue Viruses that make vaccination 
appear feasible. First of all the infection is not chronic in humans. After a short 
period of viremia (3-7 days) normal hosts develop lasting immunity to the 
serotype of the virus with which they have been infected. So, in the 1940s a live 
attenuated vaccine was created that could produce a protective immune response 
. h 10 m umans. 
There have been vaccines created for each of the four serotypes of dengue, 
but it has proven difficult to create a combined tetravalent vaccine that will have 
lasting protection against all four serotypes. Tetravalent formulations created so 
far would require many dosages and do not appear practical to administer.10 
As discussed in the history section Dengue Hemorrhagic Fever is a new 
disease that was first described in the 1950s. So although the vaccines tested in 
the 1940s proved to be effective at preventing classic Dengue fever, it is unknown 
14 
whether the vaccines will prevent the more dangerous DHF. Studies performed 
since that time have used animals, however, there is no animal model ofDHF.10 
The exact mechanism is unclear, but as mentioned earlier, secondary 
infection is a major risk factor for DHF. For example, someone who has had a 
mild dengue infection caused by DEN-I and developed immunity to this serotype 
has a much greater risk of developing the hemorrhagic form of the disease when 
infected with DEN-2 than someone who is infected with DEN-2 with no previous 
history of dengue infections.10 
Although the exact mechanism is unclear, it appears that immunity to one 
serotype is the risk factor. So creating dengue immunity by vaccination may 
actually increase a person's chance of developing DHF. 11 This theoretical 
likelihood ofDHF increases if immunity to all four serotypes is not complete and 
lasting. This aspect of the disease makes it extremely important that patients 
receive the full, effective dose of the vaccine, and considering that the highest risk 
population lives in resource poor regions, makes the challenge even more 
difficult. 10 
lB. Review of recent work on Vaccine development 
Despite the limitations to vaccine development there has been a great deal 
of support for this endeavor. In an editorial published in January 2004, Deen12 
discusses the $55 million dollar grant donated to the Pediatric Dengue Vaccine 
Initiative (PDVI) by the Bill and Melinda Gates Foundation and how the funds 
may best be used to expedite the extensive safety and efficacy research that must 
be done before a vaccine can be approved for use. Deen12 also acknowledges that 
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even with funding for research available there must also be resources to fund the 
manufacture and distribution of the vaccine to the people who need it. He calls 
for research to be done on cost effectiveness of a Dengue vaccine, hoping the 
results of such research will attract the interest of the pharmaceutical industry to 
produce such a drug and compel resource poor nations to set aside funds for 
acquiring the vaccine once it is produced. 12 
Indeed, a study on the cost effectiveness of such a vaccine was performed 
by Shepard et al13 and published in 2004. In this study a cost-effectiveness model 
was developed to determine if a pediatric tetravalent dengue vaccine given at 15 
months of age to children in Southeast Asia would be economically feasible. The 
model assumed there would be two doses and an effective vaccine would decrease 
morbidity and mortality by 89%. These estimates lead to a prediction of cost per 
DALY ofUS$ 50 for vaccination. The article compares this figure to a vector 
control program in Singapore that created a cost ofUS$ 3139 per DALY. This 
estimated cost has many hypothetical components, but it does offer evidence that 
if a safe, effective, moderately priced vaccine becomes available it could offer 
financial relief to dengue endemic countries. 13 
There are currently several vaccine candidates being developed. The first 
I will discuss is a live-attenuated vaccine containing all four serotypes 
(tetravalent). The virus was attenuated by passage through primary dog kidney 
cells (PDK). In a double blind randomized controlled trial published in 2004, 
Sabchareon et al14 studied the safety and immunogenicity of this vaccine in Thai 
schoolchildren ages 5 to 12 years. 14 
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This study was designed after several other studies on healthy adult and 
child volunteers had been performed using one and two doses of the vaccine. 
This study tests two different formulations of the vaccine given as a three dose 
series. There were 103 children used for this study. The study showed a high rate 
of seroconversion to all four viruses. Also, there was a moderate amount of 
reactivity to the vaccine that the authors believe should be improved.14 
Two interesting ideas were supported by this study. First, reactivity to the 
vaccine was less in younger children. Because primary infection with Dengue is 
usually mild in young children and worsens with age, it is plausible that reactions 
to a live-attenuated vaccine would be less in younger children.14 
Secondly, the study was conducted in Thailand where dengue has a high 
incidence and study participants were likely exposed to the wild virus. During 
this study there were no cases ofDHF. This provides a small amount of evidence 
that the vaccine is not predisposing the children to DHF.14 A study performed by 
Guy et al15 also supports the safety of this vaccine. In this study an assay was 
used to test vaccinated children and controls for Antibody Dependent 
Enhancement (ADE). This is thought to be one of the causes ofDHF. Children 
who were vaccinated with the tetravalent vaccine did not show significant ADE, 
suggesting that the vaccine had not increased their risk of developing DHF. 15 
This vaccine was only tested on children who were antibody negative for 
flaviviruses. It is unclear how children previously exposed to one of the viruses 
would react to the vaccine. This will be an important question to answer in the 
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future because a large percentage of the population in Dengue endemic regions 
have exposure to one or more of these viruses.14 
A new vaccine has been developed with recombinant DNA methods using 
a clone of the eDNA from DEN-4. This vaccine is a live-attenuated virus with a 
genetic deletion.16 In a recent placebo-controlled phase two trial performed by 
Durbin et al the vaccine was well tolerated and immunogenic when given in one 
dose. This live-attenuated virus also seems limited in its ability to infect 
mosquitoes, so there is a reduced risk of it being propagated and reverting to a 
. I . 11 Vlru ent VIruS. 
It is hoped that this virus can be used as a backbone to create vaccines for 
the other three serotypes. It is unknown at this time if a tetravalent vaccine of this 
kind will be as successful as this monovalent vaccine. This was an excellent 
study that provides strong evidence for safety and immunogenicity in healthy 
adults in a non-endemic region. However, the participants were only followed for 
42 days so additional follow-up and studies are needed.17 
The third type of vaccine candidate is a chimera that uses the backbone of 
the yellow fever vaccine virus with a substitution of the prM and E proteins with 
heterologous dengue proteins of all four serotypes. 18 This is possible because all 
viruses are in the Flaviviridae family. In a study of multiple formulations of 
tetravalent vaccines of this kind, the vaccine proved safe, immunogenic and 
effective when challenged with the wild virus in monkeys. This vaccine was 
administered in one dose, and 92% of the monkeys were protected from dengue 
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when challenged post vaccination. Work is needed to determine if the innnunity 
is lasting, as well as determine long-term safety.19 
Recombinant proteins are a third option for Dengue vaccines. In two 
recent articles by Hermida et al, DEN-1 20 and DEN-222 proteins were combined 
with a meningicoccal protein called P64k. When administered to mice these 
proteins elicited a strong neutralizing antibodies and proved effective and 
protecting mice from a dengue inoculation challenge. The authors report that a 
vaccine of this kind would be economical to produce. Further studies are needed 
to determine if vaccines of this kind would provide lasting innnunity and be safe 
to use in primates and humans.Z2 
Another possibility is a DNA vaccine. Although several are mentioned in 
the review literature22, no articles concerning these vaccines were found in this 
search. 
L C. Predictions 
There are multiple predictions about the fi.Jture of Dengue vaccines, 
however, there is little concrete evidence to support these predictions. In a recent 
editorial by Edelman23 the author gives an informative review of vaccination 
literature and then states as an expert in this field, "I am optimistic that field trials 
of 1 or more dengue vaccines will connnence within 3 years in Latin America and 
in Southeast Asia." 
The WHO website on dengue predicts that a vaccine will be ready for 
human use in the next few years. 3 The CDC's predictions are less optimistic. A 
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recently updated Dengue Website predicts five to ten years before a vaccine will 
be ready for human use.4 
Although these estimates vary the fact remains that there is no vaccine 
currently available, and the question becomes where should energy be focused 
now? 
II. Routine mosquito control programs in the form of long-term integrated 
community-based vector control 
Gubler eta! 1 state, "Ultimately, prevention of epidemic dengue and 
DHF/DSS will depend upon effective, long-term mosquito control." The 
evidence at the time suggested that the only way to achieve this goal would be 
through "Integrated community-based vector control". Programs that were run by 
the central goverrunent had failed due to lack of support and participation of the 
community and loss of goverrunental funding between epidemics.1 
IIA. Definition of Integrated community-based vector control 
An Integrated-community based vector control program involves 
educating and encouraging the public to act on eight major points: "I. DHF/DSS 
is now endemic in Puerto Rico and the US Virgin Islands; 2. The islands are at 
high risk of epidemic DHF /DSS because of the high A e. aegypti densities in all 
major cities; 3. most dengue transmission occurs in and around the home; 4. this 
happens because people accumulate excessive trash arotmd their homes, thereby 
creating mosquito breeding places; 5. dengue can be prevented by controlling 
these domestic larval habitats, but only the people involved can effectively clean 
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up the areas around their homes to prevent mosquito breeding; 6. control must be 
a community effort, because mosquitoes can fly from house to house; 7. 
insecticide spraying is expensive, is ineffective for routine mosquito control, and 
at most should only be used in emergency situations; and 8. it is the responsibility 
of the people, not the government, to prevent epidemic DHF/DSS in Puerto Rico 
and the U.S. Virgin Islands. Educational materials have been created by medical 
anthropologists, social scientists, and health educators to communicate these 
points effectively to Puerto Rico's diverse population.1 
liB. Review of Research 
The following is an analysis of the research performed on this policy since 
the time of the publication of the 199 I article. 
I. The first article obtained through the methods described above was a 
study published in 1992 conducted by Swaddiwudhipong et al24 in an urban area 
of Thailand. An intensive control program was initiated in 1988 and studied for a 
two-year period. The program consisted of an educational curriculum involving 
lectures and discussions for health care personnel, government officers, school 
children, teachers and people in the community in community gathering places 
like temples and Rotary Clubs.24 
The classes described the severity of dengue and what people needed to do 
in their own homes to remove mosquito breeding sites. Similar information was 
included in a simultaneous mass media campaign. At the same time Temephos a 
larvicidal chemical was made available at a low cost and UL V spraying twice a 
year continued by the government to kill adult mosquitos.24 
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In order to evaluate the program Aedes larval surveillance was conducted 
in March 1988 before the program began and again in June 1988. The survey 
included every other house in randomly selected sections of the community.24 
In 1989 and 1990 twice a year health workers accompanied by school 
children conducted home visits. The visits were conducted in March and June 
and during the visits community members were taught about the severity of 
Dengue and how to remove or treat larval breeding sites. Aedes larval surveys 
were conducted in and around the homes at the time of the visit and one and a half 
months later.Z4 
This article reports several larval indices. It reports percentage of houses 
with Aedes larvae, percentage of containers with larvae, and the Breteau index 
(number oflarval containers per 100 houses). It also reports on the number and 
kind of containers in the homes. This article does not give statistical analysis of 
the data.24 
This article does show that a community-based intervention is feasible and 
sustainable for two years. Also, the larval indices used in this study are sited in 
the literature as valid and useful secondary markers of success of a program. 
Because a community based program takes time to effect mosquito count, and 
even longer to effect Dengue morbidity and mortality, secondary markers such as 
larval indices and assessments of community Dengue knowledge, attitude and 
practices (KAPs) are recommended to monitor the success of the program.25 
However, it is unclear whether the changes in the indices are statistically 
significant, so effectiveness of the program carmot clearly be determined. Cost 
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effectiveness is also not discussed. All indices seem to decrease during 1990 
suggesting to the authors that during the year of a major outbreak people were 
more likely to eliminate breeding sites. 24 
This study may have been improved by offering statistical analysis of the 
indices collected. Also, it has been mentioned in the literature that UL V spraying 
is not effective and offers communities a false sense of security which in tum 
discourages people from participating in breeding site removal. 25 This may be 
occurring in this intervention as well, because the one year that spraying 
decreased due to lack of governmental funds, fewer breeding sites were found. 
This was the same year as a significant outbreak ofDHF occurred in this area, so 
it is unclear which was the motivating factor. 
2. In a follow-up report by Swaddiwudhipong et al26 a survey of 
knowledge, attitude and practices was performed on the community that received 
the educational program described above. The survey was given to 417 women 
chosen from every other household in a randomly selected section of the 
community. The survey was performed 6 weeks after the first home visit.26 
The majority of respondents knew one or two symptoms of Dengue, that it 
is transmitted by Aedes mosquitoes, and that these mosquitoes bite during the day. 
Also, most respondents believed that they were personally responsible for 
preventing Dengue in their homes and could name several common household 
breeding sites that should be eliminated or treated. This offers some evidence that 
a community-based program is acceptable to people given that one of the core 
principles is for the community to take responsibility for the program.26 
23 
The majority of these respondents had 6 years or less of education. 
Despite limited education the women were still able to understand and repeat the 
key concepts of this educational campaign. This offers some weak evidence that 
such a campaign would also be feasible in Puerto Rico, where the average 
educational level is higher. Also, this region is similar to Puerto Rico in that the 
mosquito breeding sites are mostly manmade containers (unlike Africa where 
mosquitoes breed in crab boroughs). If strong evidence becomes available to 
suggest that this program is effective, the information may be helpful in 
developing a plan for Puerto Rico. 
3. In a study conducted by Lloyd et af7 in 1992 a community-based 
communication program created to teach residents in Merida, Yucatan, Mexico 
how to eliminate larval production sites proved to be effective. This study was 
implemented in six communities, and communities were randomized to treated or 
untreated control groups. The communities were evaluated before intervention, 
immediately after intervention, and six months post-intervention. Significant L 
improvements in the knowledge and behavior of the intervention group were 
found at both post-intervention evaluations.27 
The Breteau index (number of positive containers/100 houses surveyed) 
remained unchanged for the intervention group while it significantly increased for 
the control group. The authors conclude that this was most likely due to the 
decrease in trash collection services available in the community. So, the 
intervention group was working hard to minimize the accumulation of breeding 
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sites around their homes (usually disposable containers), but had trouble 
disposing of sites that were already present. 27 
Even though the Breteau index is considered a valid measurement, the 
index in this intervention program remained unchanged in the intervention group. 
It would be expected that a true behavior change in participants would lead to a 
reduction in breeding site. However the lack of increase in comparison to the 
controls and the increased knowledge does suggest that this intervention is 
somewhat effective, and the results that were sustained at the six-month time 
point suggests that it may also be sustainable. The study was well designed and 
controlled.Z7 
This study offers strong evidence that educational campaigns can change 
knowledge about Dengue vectors, however the amount of success in behavioral 
change appears limited by the lack of community services, like garbage 
collection. Also, in a report of the methods used to develop and implement this 
program the authors report few difficulties in gaining the support and 
participation of the community and completing the project within four months. 28 
This offers strong evidence that the intervention is both feasible and currently 
acceptable to a DHF endemic community. There was no information on costs. 
4. In 2002 spraying with ultra low volumes (UL V) of malathion was still a 
widely recommended and practiced form of vector control. Espinoza-Gomez et 
al29 developed a study to evaluate the effect of an integrated community-based 
vector control campaign for reducing breeding sites, and compare its effect with 
those obtained by UL V spraying of malathion. 29 
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The study was a randomized community trial in Colima, Mexico. The 
communities were randomized to one of four conditions: educational campaign 
alone, UL V malathion spraying alone, both treatments simultaneously, or no 
treatment. Assessments were performed before the interventions began and six 
months post -intervention and consisted of an entomological survey and a KAP 
survey of each house.29 
The educational campaign group had significantly greater reduction in 
larvae positive breeding sites than the UL V spraying only group and the 
combined education and spraying group. The authors concluded that the UL V 
spraying might have lessoned the positive effect of the educational campaign in 
the combined intervention, perhaps due to a false sense of security provided by 
chemical spraying. The KAP scores did not differ between groups, suggesting 
that this survey of knowledge, attitude and practices may not be a helpful 
indicator of success of a program. 29 
This study is well designed and well controlled and offers strong evidence 
that a community based educational campaign can be effective at reducing 
breeding sites. It offers weak evidence about sustainability. The effects were 
seen at six months post intervention, but at no time points in the future. The 
authors report no difficulties with gaining support and participation from the 
community suggesting it is feasible and acceptable, but give no information about 
costs?9 
5. In an article by Madeira et al30 an educational campaign performed in 
fifth and sixth graders in Brazil was evaluated. The intervention consisted of four 
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fifty-minute didactic activities over the course of two weeks. There was a 
significant increase in knowledge about dengue and control measures in the 
intervention group when compared to controls. The authors site past examples of 
how school children were instrumental in motivating communities to control 
filarial and chagas diseases and predict that the same process could occur with 
Dengue?0 
This article offers evidence that knowledge may be increased, but gives no 
evidence that this has had any effect on behavior in the community. There is no 
evidence concerning sustainability or cost effectiveness. The authors mention no 
problems gaining the support and participation ofthe children in these activities, 
so it appears that it is feasible and acceptable. However, assessments at future ~ 
' t 
time points and indicators of behavioral changes would be helpful in determining 
• l ' 
the utility of this intervention?0 
6. Kay et al31 studied the effect of an integrated community-based control 
program in Vietnam. Out often communes, six were chosen based on high i 
r-
dengue incidence to participate in the intervention and the other four were used as 
the control group. The interventions involved treatment of permanent water 
containers with Mesocyclops species (predacious cyclopoids that feed on 
mosquito larvae), educational programs for the community and home visits, 
recycling incentives to encourage the disposal of manmade containers, and 
community cleanup projects.31 
At the end of the study the A e. Aegypti population in the six treated 
communes ranged from 0 to 0.3% of the total population before the intervention. 
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The vector population in the four control communes at the end of the study ranged 
from 14.4 to 367.0% of the original population. It was difficult to determine how 
these results affected the level of dengue transmission during this time. Dengue is 
often asymptomatic in children and people in these communities were resistant to 
having blood samples collected.31 
This study provided strong evidence that a community-based vector 
control can be effective at eradicating vectors from dengue endemic regions. This 
study also provided two-year follow up data that provided strong evidence that the 
program was sustainable. Also, the authors mention that they received political 
and community support for the program, and has been implemented in many other 
communities in Vietnam. This provides evidence that it is feasible and 
acceptable. However there was no information about costs. 1bis study could 
have been improved by randomizing communities and conducting proactive 
surveillance to determine if the dengue transmission rate is affected as well.31 
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7. In a study conducted in Puerto Rico by Winch et a132 several ! 
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components of a community based program were evaluated using KAP surveys, 
larval indices, focus groups and interviews. The intervention consisted of 
televised public service announcements and posters, educational programs for 
elementary and pre-school children, and an exhibit at a children's museum.32 
Exposure to the programs was associated with increased dengue 
L 
knowledge, and to a lesser degree, increased performance of dengue prevention 
behaviors like covering tires, and slightly lower indices of mosquito infestation. 
This study provides evidence that this kind of intervention involving children may 
28 
be effective at changing the behavior of parents may be effective. Randomizing 
participants may have increased the strength of the evidence. It provides strong 
evidence that the programs are feasible and acceptable, but no evidence about 
costs or sustainability was presented. 32 
8. In recent articles the definition of integrated long-term community 
based control has changed somewhat. Instead of a program that must be the 
responsibility of the community to finance and maintain a slightly different 
approach, called "intersectoral coordination" is advocated. The activities used for 
vector control are still the same, involving education and activities to dispose of 
or treat mosquito breeding sites, but responsibility, funding and planning includes 
sources outside the community. Sanchez et al33 states the following, "sustained 
dengue control requires partnerships among donors, the public sector, civil 
society, non-governmental organizations, and the private for profit sector, and the 
interlinking of politicians, administrators, engineers, urban planners, sanitarians 
and environmental groups into intersectoral teams." 
Despite these changes, the activities, control practices, and need for 
community participation remains unchanged, so intersectoral coordination 
programs will be included in this section. 
In a recently published article Sanchez et ae3 reports on a pilot project that 
involves intersectoral coordination in Cuba. The community was involved in all 
levels of planning and implementation of this intervention, but in addition an 
intersectoral team was created to help plan and implement the program. A 
community similar to the one receiving the intervention was defined as the 
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control. The interventions consisted of eliminating unused containers in houses 
and surrotmding areas, covering water tanks and cleaning neighborhoods and 
public areas. In the control area the national dengue control program continued to 
be carried out without input from the community or other sectors outside the 
government. A KAP survey and collection oflarval indices were collected from 
both groups before and after the one-year intervention.33 
This study found that knowledge about breeding sites and dengue 
symptoms increased significantly, and House Index (number of containers with 
larvae/number of all containers *I 00) decreased significantly in the intervention 
community while there were no significant changes in the control group.33 
This study offers evidence that a community-based program with the 
addition ofintersectoral coordination may be effective. Including multiple 
communities randomized to intervention and control groups could have 
strengthened the evidence. The project is feasible and accepted by the 
community. There is no information about costs. The intervention was sustained 
for one year, which is a longer period of time than most studies, and gives some 
evidence that the program is sustainable.33 
9. The final article in this review was published in February 2005 by Kay 
et al34 and is a follow-up report to a previously reviewed study. The previously 
described community based vector control program studied in Vietnam. The 
program was expanded to include 37 communes with complete eradication of A. 
aegypti in 32 of these communes and very low mosquito populations in the other 
5. There have been no cases of dengue detected in the treated communes since 
30 
2002 despite rates as high as 112.8 per 100,000 in the surrounding untreated 
communes.
34 
At the end of this article the authors state that additional research will be 
performed this year to evaluate cost effectiveness but state that the estimated cost 
of the program is 20 cents per person year. It is unclear what this figure means in 
terms of DALY s so the evidence concerning cost effectiveness is inconclusive at 
this time. However, this article provides strong evidence that this intervention is 
effective at reducing mosquito population, and most likely dengue morbidity and 
mortality as well. It also provides strong evidence that the program is sustainable 
and acceptable to the communities. 
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C. Table of evidence for long term community-based vector control 
Weak evidence to support+ Weak evidence against-
Moderate evidence to support ++ Moderate evidence against - -
Strong evidence to support +++ Strong evidence against - - -
Article Current Cost Acceptable Sustainable Effectiveness 
Feasibility effective to people 
1. + + 
Swaddiwu 
dhiPODI! ; 
2. + + r-i 
Swaddiwu 
dhipong 
3. Lloyd +++ +++ + + 
4. +++ +++ + +++ 
Espinoza-
Gomez 
5. Madeira +++ +++ 
6. Kay +++ +++ +++ +++ 
7. Winch +++ +++ ++ 
8. Sanchez +++ +++ + ++ 
9. Kay +++ + +++ +++ +++ 
! 
Discussion I 
Vaccination 
Vaccination could potentially be a cost-effective method of dengue virus 
control, and many countries are interested in obtaining a tetravalent vaccine. A L 
vaccination campaign would be easier to implement than vector control, and has 
been a very attractive option to donors. This review showed that recent advances 
have been made in vaccine-related research. However, a safe and effective 
32 
tetravalent vaccine for dengue has not been developed and may not be available 
for years to come. Dengue presents a unique challenge to vaccine developers, in 
that antibodies to the disease are a major risk factor for the hemorrhagic form of 
the disease. It is still unclear to what degree and for how long immunity must last 
to protect patients from the disease without increasing the risk ofDHF. 
All vaccine trials to date have been performed on healthy controls with no 
previous exposure to viruses in the Flaviviridea family. Large proportions of the 
populations in dengue endemic regions are already seropositive for these viruses. 
Vaccine safety and efficacy have not been demonstrated in HIV-positive patients, 
who comprise a large proportion of the population in the regions most affected by 
dengue.23 • 
Questions remain regarding ethical issues in vaccine testing. Is it 
acceptable to administer a vaccine that may increase the chances ofDHF? For 
patients that have already received the vaccine (i.e.: Thai children) how long 
should investigators wait before the vaccine is considered safe to use? Some have 
suggested that DHF may still be a risk twenty years after initial exposure. Should 
entire populations be vaccinated after five years of safety testing? Also, if a 
vaccine does become available, is it safe to discontinue vector control programs? 
And if so, will herd immunity be enough to break the transmission cycle and 
protect those in whom vaccination is contraindicated? These issues may cause as 
many limitations on vaccine development as the current technological barriers. 
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Long term integrated community-based vector control 
Evidence 
A review of the recent literature on long-term integrated community-based 
vector control programs provides evidence that this policy is feasible, acceptable 
to communities, sustainable, effective at lowering the mosquito population, and 
probably effective at reducing morbidity and mortality from dengue. 
The one limitation for this policy may be cost-effectiveness. There is little 
evidence about the costs of this program. The ongoing analysis in Vietnam will 
help determine the overall cost-effectiveness of a vector control program. It could 
be harmful to waste valuable resources on a program that does not prove to be 
cost-effective. 
Also, it will be helpful to follow the long-term incidence, morbidity and 
mortality of dengue in the Vietnamese communities. Dengue epidemics only 
occur every few years, so the apparent absence ofthe disease for several years, 
although promising, is not conclusive evidence that the disease might have been 
eradicated. 
Generalizability 
Even though many of these studies were performed in places other than 
Puerto Rico, there are many similarities among these different locations. For 
example, the communities in Vietnam have dealt with water shortages. Most L 
participants in the study communities have water piped into their homes and store 
water in large containers to save for times of shortage. These containers are one 
of the primary sources of breeding sites. Since the same problem occurs in Puerto 
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Rico,32 the program that has been so successful and sustainable in Vietnam may 
also be effective in Puerto Rico. 
Although the same copepod and larvivorous fish that were used in 
Vietnam are not indigenous to Puerto Rico, the same process of testing and 
treating water sources with larvicidal species or chemicals can be used. 
Also, the educational level in Puerto Rico is higher than that of many of 
the communities studied in the programs reviewed above and baseline level of 
dengue knowledge is already high in Puerto Rico.32 This suggests that some of 
the obstacles that had to be overcome in communities in Mexico and Vietnam, 
may not be problems in Puerto Rico. Perhaps more effort and resources can be 
devoted to mobilizing people rather than educating them. For example, incentives 
can be offered for recycling containers and neighborhood cleanups can be 
organized. 
Secondary Findings 
Over the past fourteen years it was discovered that the policy oflong term 
integrated community vector control could be made more successful by adding 
input from other sectors. Some problems required intervention by local, state and 
national governments. For example, some behaviors like storing water and 
accumulating trash around homes were being driven by water shortages and lack 
of garbage collection services. In Puerto Rico, a successful vector control L 
program will require input from the community as well as the government. 
Studies in the past have shown that UL V spraying in places like Puerto 
Rico neither reduces the mosquito population long-term, nor reduces the 
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incidence of dengue infection. 35 1n this review, it was shown that UL V spraying 
actually decreased the effectiveness of the community-based program. 
Implications 
From the evidence presented here, the best policy for the reduction of 
morbidity and mortality caused by dengue virus infection in Puerto Rico is a 
policy that includes long-term integrated community vector control as desribed by 
Gubler/ with the addition of governmental input and support. This policy has the 
best chance of providing protection from dengue for all ofPuertoRico's citizens. f 
Furthermore, all routine UL V spraying should be discontinued to increase the 
effectiveness of this program and to decrease costs. 
To test the effectiveness of this policy for the :frrst several years, larval 
indices would be most helpful. Data indicate that knowledge, attitude and 
practices (KAP) survey scores do not always correlate with actual behavior. 
When the program is successful at eliminating the mosquito population, dengue 
morbidity and mortality should be followed as an indicator of success. 
Although costs and simplicity may make vaccination appear to be an 
attractive option, it is important to focus resources on the policy that is currently 
safe, feasible, acceptable, sustainable and effective. 
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